Menha Swellam

Prof. Menha Swellam

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2019 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
MSMenha Swellam
Menha Swellam
LALobna Ezz El Arab
Lobna Ezz El Arab
AAAmr S. Al-Posttany
Amr S. Al-Posttany
SSSamy B. Said
Samy B. Said

18 June 2018 in Archives of Physiology and Biochemistry
Verified
Journal Article
Closed access
MSMenha Swellam
Menha Swellam
RZRasha F. K. Zahran
Rasha F. K. Zahran
HTHossam Abo El-Sadat Taha
Hossam Abo El-Sadat Taha
Nashwa El-KhazragyNashwa El-Khazragy
Nashwa El-Khazragy
CACamelia Abdel-Malak
Camelia Abdel-Malak
Aberrant expression of miRNAs has a link with tumorgenesis and their deregulation is reported in biological fluids of cancer patients. Authors aimed to investigate the diagnostic role of miRNA-17-5p, miR-155 and miRNA-222 in serum samples from breast cancer patients (n = 80), benign breast patients (n = 40) and healthy individuals (n = 30) using quantitative real-time PCR technique. Median levels of investigated markers revealed significant increase in primary breast cancer followed by benign and control groups. Investigated miRNAs reported significant relation with clinical stages and histological grading, while only miRNA-17-5p showed significant relation with hormone receptors. When considering investigated miRNAs as compared to tumor marker, their sensitivities were superior over tumor markers for early diagnosis of breast cancer, detection of early stages and low grades breast cancer patients. In conclusion, detection of the miRNA-17-5p, miR-155 and miRNA-222 expression levels in serum samples is significant promising molecular markers for early breast cancer diagnosis.

25 October 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Nashwa El-KhazragyNashwa El-Khazragy
Nashwa El-Khazragy
MNMohamed Ahmed Noshi
Mohamed Ahmed Noshi
CACamelia Abdel‐Malak
Camelia Abdel‐Malak
RZRasha F. Zahran
Rasha F. Zahran
MSMenha Swellam
Menha Swellam

1 June 2018 in Clinical Biochemistry
Verified
Journal Article
Closed access
MSMenha Swellam
Menha Swellam
HMHekmat M. El Magdoub
Hekmat M. El Magdoub
NHNaglaa M. Hassan
Naglaa M. Hassan
MHMona M. Hefny
Mona M. Hefny
MSMohamed Emam Sobeih
Mohamed Emam Sobeih

1 March 2019 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MSMenha Swellam
Menha Swellam
ARAmal Ramadan
Amal Ramadan
EEEnas A. El‐Hussieny
Enas A. El‐Hussieny
NBNoha M. Bakr
Noha M. Bakr
NHNaglaa M. Hassan
Naglaa M. Hassan
LELobna R. EzzElArab
Lobna R. EzzElArab

30 May 2019 in Archives of Physiology and Biochemistry
Verified
Journal Article
Closed access
MSMenha Swellam
Menha Swellam
RZRasha F. K. Zahran
Rasha F. K. Zahran
SGSamar Ayman Ghonem
Samar Ayman Ghonem
CACamelia Abdel-Malak
Camelia Abdel-Malak
Background: Accumulating evidence reveals that microRNA 27a (miR 27a) is implicated in the pathogenesis of cancer. However, its diagnostic role in breast cancer (BC) still needs investigation. Materials and methods: MiR 27a expression was assessed in serum samples from patients with primary BC (n = 100), benign breast lesions (n = 30) and control group served as healthy volunteers (n = 20) using quantitative real-time PCR. Results: Both expression and mean rank of miR 27a and tumor markers among BC patients as compared to the other two groups. Clinicopathological characteristics showed significant relation with miRN 27a expression for clinical stage, histological grading, ER receptor and HER-2/neu. The diagnostic efficacy for miR 27a was superior to both tumor markers for early detection of BC especially high-risk BC groups. Conclusion: Detection of miR 27a expression may serve as a potential sensitive minimally invasive molecular marker for early detection of primary BC.